CompoundedPremiumPrescription Required

    Tirzepatide

    Up to 20.9% body weight reduction in clinical trials. Activates both GLP-1 and GIP for enhanced results.

    Tirzepatide prescription medication from RespondWell
    First order: $169Same price, every dose

    Second and subsequent refills $279/per 30-day supply of medication or from $499 for a 90 day supply.

    Treatment plan includes no-cost medical evaluation

    Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. See Safety Info for details.

    Free provider visit • You pay $0 if not approved
    • Doctor Prescribed
    • 100% Online
    • UPS 2nd Day Air
    • No Waiting Rooms
    • No Membership Fees
    • FSA/HSA Eligible

    Key Benefits

    Most effective weight loss medication in clinical studies
    Dual GLP-1/GIP action for enhanced results
    Up to 20.9% body weight reduction in clinical trials¹
    Improved blood sugar control
    Reduced appetite and cravings

    Ideal For:

    Those seeking maximum weight loss results
    Patients with significant weight to lose (BMI 30+)
    Those who prefer the enhanced dual-receptor mechanism
    Patients with or at risk for type 2 diabetes
    Adults with moderate-to-severe obstructive sleep apnea

    How It Works

    From Zero to Approved in Under 24 Hours
    We know you've got 10 minutes between calls at best. So we made this fast.

    01

    Choose

    Select your treatment

    ⏱ 2 MINUTES

    02

    Consult

    Quick online assessment

    ⏱ 5 MINUTES

    03

    Prescribe

    Provider reviews & approves

    ⏱ <4 hours (AVG)

    04

    Deliver

    Ships to your door

    ⏱ <1 Week*

    *Timelines shown reflect our average turnaround times (asynchronous) and are not guaranteed.

    See if you Qualify

    Answer a few simple questions to check eligibility.

    About Our Medications

    Our treatments contain active pharmaceutical ingredients that conform to USP (United States Pharmacopeia) monograph standards and are custom-compounded by licensed 503A and 503B pharmacies to meet your individual needs. Compounded medications are not FDA-approved finished drug products. The suggested formulations are provided for reference only and are based on formulations that have historically been prescribed by duly licensed prescribers. All medications are prepared in accordance with a valid prescription from a licensed healthcare provider following a medical consultation.

    Medical Consultation Required

    Our licensed medical providers will evaluate your health history and goals to determine the most appropriate treatment option for you. Prescriptions are subject to medical evaluation and are not guaranteed. If we are unable to prescribe treatment after your consultation, you pay zero. Independent clinical services provided by: Wasef Health, PC c/o Michael Wasef MD. Licensed in all 50 states + DC.

    Clinical References

    1. 1Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216.
    2. 2Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503–515.
    3. 3Del Prato, S., Kahn, S. E., Pavo, I., et al. (2021). Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4). The Lancet, 398(10313), 1811–1824.
    4. 4Malhotra, A., Grunstein, R. R., Gao, L., et al. (2024). Tirzepatide for the treatment of obstructive sleep apnea and obesity. New England Journal of Medicine, 391(13), 1193–1205.
    5. 5Caldow MK, Ham DJ, Trieu J, Chung JD, Lynch GS, Koopman R. Glycine supplementation during calorie restriction accelerates fat loss and protects against further muscle loss in obese mice. Clinical Nutrition. 2016;35(5):1118–1126.
    6. 6Caldow MK, Ham DJ, Chee A, Trieu J, Naim T, Stapleton DI, Swiderski K, Lynch GS, Koopman R. Glycine Protects Muscle Cells From Wasting in vitro via mTORC1 Signaling. Frontiers in Nutrition. 2019;6:172.
    7. 7Ham DJ, Gleeson BG, Chee A, Baum DM, Caldow MK, Lynch GS, Koopman R. L-Glycine Restores the Anabolic Response to Leucine in a Mouse Model of Acute Inflammation. American Journal of Physiology - Endocrinology and Metabolism. 2016;310(11):E970–E981.